Jarrett T. Disbrow - 06 Nov 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Business Officer
Signature
/s/ Mark Oki as attorney-in-fact for Jarrett Disbrow
Issuer symbol
AYTU
Transactions as of
06 Nov 2024
Net transactions value
$0
Form type
4
Filing time
08 Nov 2024, 19:49:42 UTC
Previous filing
15 Aug 2023
Next filing
10 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Employee Stock Option (Right to Buy) Award $0 +7,000 $0.000000 7,000 06 Nov 2024 Common Shares 7,000 $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025.